P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure

Environmental Health and Preventive Medicine

Volumn 18, Issue 2, 2013, Pages 121-129

  Koizumi, Akio ^a   Kobayashi, Hatasu ^a   Liu, Wanyang ^a   Fujii, Yukiko ^a   Senevirathna, S T M L D ^a   Nanayakkara, Shanika ^a   Okuda, Hiroko ^a   Hitomi, Toshiaki ^a   Harada, Kouji H ^a   Takenaka, Katsunobu ^b   Watanabe, Takao ^c   Shimbo, Shinichiro ^d  

^a KYOTO UNIVERSITY   (Japan)

^b Takayama Red Cross Hospital   (Japan)

^c Tohoku Bunkyo University   (Japan)

^d KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Hypertension; Moyamoya disease; P.R4810K; RNF213; Systolic blood pressure

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MOYAMOYA DISEASE; MUTATOR GENE; RNF213 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 84878521797     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-012-0299-1     Document Type: Article

References (38)

1. Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. Brain Nerve. 1957;9:37-43.
2. Suzuki J, Takaku A. Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288-99.
3. Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025-9.
4. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533-7.
5. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179-82.
6. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49:278-81.
7. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930-5.
8. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70:2357-63.
9. Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15:94-104.
10. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34-40.
11. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542.
12. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056-66.
13. Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31:733-7.
14. Togao O, Mihara F, Yoshiura T, Tanaka A, Kuwabara Y, et al. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183:119-22.
15. Limaye CS, Khude S, Pednekar SJ. Moyamoya disease with hypertension in a young adult. J Assoc Physicians India. 2011;59:124-6.
16. Shimbo S, Zhang ZW, Moon CS, Watanabe T, Nakatsuka H, et al. Correlation between urine and blood concentrations, and dietary intake of cadmium and lead among women in the general population of Japan. Int Arch Occup Environ Health. 2000;73:163-70.
17. Watanabe T, Shimbo S, Nakatsuka H, Koizumi A, Higashikawa K, et al. Gender-related difference, geographical variation and time trend in dietary cadmium intake in Japan. Sci Total Environ. 2004;329:17-27.
18. Koizumi A, Yoshinaga T, Harada K, Inoue K, Morikawa A, et al. Assessment of human exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in Japan using archived samples from the early 1980s and mid-1990s. Environ Res. 2005;99:31-9.
19. Koizumi A, Harada KH, Inoue K, Hitomi T, Yang HR, et al. Past, present, and future of environmental specimen banks. Environ Health Prev Med. 2009;14:307-18.
20. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207-10.
21. Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677-87.
22. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-9.
23. Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in East Asians. Nat Genet. 2011;43:531-8.
24. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amon CI. Shifting paradigm of association studies: value of rare single nucleotide polymorphisms. Am J Human Genet. 2008;82:100-12.
25. Slager SL, Huang J, Vieland VJ. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol. 2000;18:143-56.
26. Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149-50.
27. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60-9.
28. Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-72.
29. Draheim CC, Geijer JR, Dengel DR. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. Am J Cardiol. 2010;106:1512-6.
30. Koduri PR, Agbemadzo B, Nathan S. Hemoglobin S-C disease revisited: clinical study of 106 adults. Am J Hematol. 2001;68:298-300.
31. Reid HL, Anah CO. Haemorheological parameters in hypertensive Nigerians with and without sickle-cell trait. Angiology. 1985;36:379-86.
32. Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Schina M, et al. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res. 2011;303:317-25.
33. Eu-ahsunthornwattana J, Trachoo O, Dejsuphong D, Tunteeratum A, Srichan K, et al. Noonan syndrome, metabolic syndrome and stroke-in-the-young: coincidence, causal or contribution? J Med Assoc Thai. 2010;93:1084-7.
34. Rokicki W, Rokicka A. Noonan syndrome coexisting with essential arterial hypertension in 8 year old boy. Wiad Lek. 2002;55:488-93.
35. Di Bartolomeo R, Polidori G, Piastra M, Viola L, Zampino G, et al. Malignant hypertension and cerebral haemorrhage in Seckel syndrome. Eur J Pediatr. 2003;162:860-2.
36. Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617-27.
37. Miskinyte S, Butler MG, Herve D, Sarret C, Nicolino M, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88:718-28.
38. Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55:1389-97.